Therapeutic Area Market Research Reports & Industry Analysis

The Therapeutic Area Market refers to a specific category of diseases or conditions for which there are known medical treatments or promising treatments in development. It is a way to classify drugs without reference to the type of therapy, form of action, or the company that makes it, but instead to look at the disease it treats.

Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.

Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.

...Show More ...Show Less


Therapeutic Area Industry Research & Market Reports

  • Global Musculoskeletal System Disorder Market Research Report 2024

    ... of 4.19% during the forecast period 2024-2030. North American market for Musculoskeletal System Disorder is estimated to increase from $ 77023 million in 2023 to reach $ 100034 million by 2030, at a CAGR of ... Read More

  • Glaucoma Therapeutics

    ... at a CAGR of 3.5% over the analysis period 2023-2030. Prostaglandins Analogs, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$2.9 Billion by the end of ... Read More

  • Respiratory Protection Equipment

    ... by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Air Purifying Respirators, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$15.3 Billion ... Read More

  • Therapeutic Respiratory Devices

    ... by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. Positive Airway Pressure Devices, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$32.3 ... Read More

  • Behavioral Rehabilitation

    ... at a CAGR of 5.8% over the analysis period 2023-2030. Outpatient Setting, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$207.4 Billion by the end of ... Read More

  • Orthopedic Navigation Systems

    ... by 2030, growing at a CAGR of 14.7% over the analysis period 2023-2030. Electromagnetic Technology, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$286.9 Million by ... Read More

  • Osseointegration Implants

    ... at a CAGR of 7.1% over the analysis period 2023-2030. Knee Implants, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$5.1 Billion by the end of ... Read More

  • Prostate Cancer Diagnostics

    ... by 2030, growing at a CAGR of 13.1% over the analysis period 2023-2030. Preliminary Test, one of the segments analyzed in the report, is expected to record a 12.4% CAGR and reach US$10.0 Billion by ... Read More

  • Transcatheter Pulmonary Valves

    ... by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Balloon-Expanded Technology, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$74.1 Million by ... Read More

  • Metabolic Disorder Therapeutics

    ... by 2030, growing at a CAGR of 6.8% over the analysis period 2023-2030. Diabetes Therapeutics, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$91.9 Billion by ... Read More

  • Vaginitis Therapeutics

    ... at a CAGR of 7.5% over the analysis period 2023-2030. Anti-Bacterial, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$2.7 Billion by the end of the ... Read More

  • Bone Morphogenetic Proteins

    ... by 2030, growing at a CAGR of 2.4% over the analysis period 2023-2030. Recombinant human bone morphogenetic protein-2 (rhBMP-2), one of the segments analyzed in the report, is expected to record a 2.6% CAGR and ... Read More

  • Cartilage Degeneration Therapy

    ... by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Joint Replacements, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$7.7 Billion by ... Read More

  • Gastroesophageal Reflux Disease (GERD) Therapeutics

    ... is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2023-2030. Antacids, one of the segments analyzed in the report, is expected to record a 4.4% CAGR ... Read More

  • Chronic Myelogenous Leukemia Treatment

    ... reach US$10.1 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Disease Specific Treatment, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and ... Read More

  • Retinal Laser Equipment

    ... by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$693.0 Million by ... Read More

  • Pregnancy and Fertility Testing Products

    ... is expected to reach US$12.5 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 10.9% ... Read More

  • Hematology Testing Products

    ... by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Hematology Testing Instruments & Software, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach ... Read More

  • Genitourinary Drugs

    ... at a CAGR of 2.4% over the analysis period 2023-2030. Urologicals, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$10.7 Billion by the end of the ... Read More

  • Orthopedic Digit Implants

    ... by 2030, growing at a CAGR of 5.4% over the analysis period 2023-2030. Titanium Material, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$139.3 Million by ... Read More

  • Intravaginal Insemination

    ... at a CAGR of 7.3% over the analysis period 2023-2030. The U.S. Market is Estimated at US$123.9 Million While China is Forecast to Grow at 10.7% CAGR The Intravaginal Insemination market in the U.S. is ... Read More

  • Ocular Prosthesis

    ... at a CAGR of 6.5% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$1.3 Billion by the end of ... Read More

  • Oncology Based In-Vivo CRO

    ... reach US$2.5 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Solid Tumors Indication, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and ... Read More

  • Urology Surgical Instruments

    ... by 2030, growing at a CAGR of 7.6% over the analysis period 2023-2030. Consumables & Accessories, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$13.5 Billion ... Read More

  • Microwave Ablation

    ... at a CAGR of 13.0% over the analysis period 2023-2030. Liver Cancer Application, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$215.5 Million by the end ... Read More

Cookie Settings